4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001104659-18-000890
Options or other derivatives
- Director acquired 8,267 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BLECH ISAAC · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +8,267 | $3.20 | 2027-12-30 | 8,267 | 8,267 | D |
Loading xslF345X03/a4.xml…